Mercer Global Advisors
RGNX icon

Mercer Global Advisors’s Regenxbio RGNX Stock Holding History

Mercer Global Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$200K Sell
23,840
-300
-1% -$3.15K ﹤0.01% 2837
2025
Q4 		$348K Buy
24,140
+4,224
+21% +$52.6K ﹤0.01% 2116
2025
Q3 		$192K Buy
+19,916
New +$176K ﹤0.01% 2400
2023
Q1 		– Sell
-13,761
Closed -$312K – 2029
2022
Q4 		$312K Buy
13,761
+2,183
+19% +$49.4K ﹤0.01% 1482
2022
Q3 		$306K Buy
+11,578
New +$343K ﹤0.01% 1393

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mercer Global Advisors's RGNX Position: Q1 2026 in Review

Mercer Global Advisors reduced its Regenxbio (RGNX) stake by 1.2% in Q1 2026, selling an estimated $3.15K and leaving 23,840 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #2837.

Mercer Global Advisors first reported a position in RGNX in Q3 2022 and has held it in 5 quarters since. The position peaked at $348K in Q4 2025. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • Mercer Global Advisors held 23,840 shares of Regenxbio worth $200K as of Q1 2026.
  • Mercer Global Advisors sold 300 Regenxbio shares in Q1 2026, an estimated $3.15K.
  • Regenxbio made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #2837 holding.
  • Mercer Global Advisors first reported a position in Regenxbio in Q3 2022 and has held it in 5 quarters since.
  • Mercer Global Advisors's Regenxbio position peaked at $348K in Q4 2025.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.